Fosun Pharma (Shanghai Fosun Pharmaceutical (Group) Co., Ltd.) announced on June 21, 2024 that it provided guarantees for multiple subsidiaries. This includes Jianjia Medical's guarantee for financing up to RMB 10 million applied by Shanghai Jianyuankangfu to Bank of Shanghai, and Fosun Pharmaceutical Industry's guarantee for financing up to RMB 100 million applied by Chaohui Pharmaceutical to Industrial and Commercial Bank of China for working capital loan. In addition, Fosun Pharmaceutical also provided guarantees for financing lease transactions between Guangzhou New Market Hospital and Xuzhou Xinchender Mother and Child Hospital and Su Silver Renting, with amounts of RMB 85 million and RMB 50 million respectively. The counter-guarantee arrangement includes shareholders such as Shanghai Diemu Medical and Ningbo Lixing providing stock pledges for relevant...Show More

Fosun Pharma (Shanghai Fosun Pharmaceutical (Group) Co., Ltd.) announced on June 21, 2024 that it provided guarantees for multiple subsidiaries. This includes Jianjia Medical's guarantee for financing up to RMB 10 million applied by Shanghai Jianyuankangfu to Bank of Shanghai, and Fosun Pharmaceutical Industry's guarantee for financing up to RMB 100 million applied by Chaohui Pharmaceutical to Industrial and Commercial Bank of China for working capital loan. In addition, Fosun Pharmaceutical also provided guarantees for financing lease transactions between Guangzhou New Market Hospital and Xuzhou Xinchender Mother and Child Hospital and Su Silver Renting, with amounts of RMB 85 million and RMB 50 million respectively. The counter-guarantee arrangement includes shareholders such as Shanghai Diemu Medical and Ningbo Lixing providing stock pledges for relevant guarantee projects. As of the announcement date, the actual external guarantee amount of Fosun Pharmaceutical Group was approximately RMB 27.56 billion, accounting for 60.34% of the net assets attributable to shareholders of the listed company as of the end of 2023 audited, and without any overdue guarantee matters. This guarantee matter has been approved by the 2022 Shareholders' Meeting and is within the approved limit range of the Board of Directors.